Trump’s Proposal for Hamas Disarmament
President Donald Trump announced a new agreement for Hamas to disarm and Israel to pull back its forces from Gaza. Significant obstacles, conditions, and extended timelines are still in place, needed to end the conflict. The announcement comes nine months following a U.S.-brokered ceasefire, which faced an impasse, particularly concerning Hamas disarmament and Gaza’s rebuilding. Trump’s 20-point plan insists on Hamas relinquishing its arms and destroying tunnel networks. Additionally, the plan outlines Israeli withdrawal, a new Palestinian government, and an international security force deployment.
Upcoming Cabinet Meeting at Camp David
President Trump will hold a Cabinet meeting at Camp David, marking the first such meeting of his second term at the location after a previous attempt was canceled due to bad weather. The meetings, known for extensively praising Trump, allow all attendees to update him on their respective departments. These gatherings remain open to media throughout, underscoring Trump’s commitment to transparency, as emphasized by White House press secretary Karoline Leavitt.
Controversy Over Attorney General Nomination
Trump suggested possibly retracting acting Attorney General Todd Blanche’s nomination due to Senate Republicans’ demands for a sweeping tax audit immunity deal favorable to Trump and his family. The nomination has stalled amidst failed negotiations and a judge’s criticism of Trump’s IRS lawsuit settlement. Senators Cornyn and Tillis expressed concerns, suggesting the White House’s lack of agreement may hinder Blanche’s confirmation.
FIFA Adviser Resigns in Protest
Carlos Cordeiro, a senior FIFA adviser, resigned to oppose FIFA’s private equity plan for the World Cup. He criticized the proposal as detrimental to football and clarified his position against the $20 billion commercial subsidiary. Cordeiro’s statement strongly urged other FIFA staff to voice their concerns.
End of Medicare Drug Subsidy Program
The Trump administration announced the end of a subsidy program aiding Medicare prescription drug costs, potentially increasing costs for millions of older adults in 2027. Originally introduced under the Biden administration, the program aimed to alleviate costs following the 2022 Inflation Reduction Act. The termination might have political impacts during an election year as Medicare beneficiaries confront potential cost increases.